83例活检证实结节病性葡萄膜炎的长期视觉与全身预后
回顾性分析2004年4月至2016年1月里昂大学医院83例活检证实结节病性葡萄膜炎患者(随访至少3年),中位发病年龄52岁,女性占77.1%。31例初诊时已有全身结节病,52例初诊为孤立性葡萄膜炎,后者中7.7%(n=4)在中位随访60个月后出现眼外病变。60.2%患者视觉完全恢复,89.2%双眼最佳矫正视力>20/50,无患者出现双侧严重视力损害或失明;慢性黄斑水肿(p=0.009)和持续性眼内炎症(p=0.0005)与视力预后差相关。
要点
- 活检证实结节病性葡萄膜炎总体视觉预后良好,89.2%患者双眼最佳矫正视力>20/50。
- 孤立性葡萄膜炎起病者仅7.7%(n=4)在中位随访60个月后出现眼外病变。
- 慢性黄斑水肿(p=0.009)和持续性眼内炎症(p=0.0005)与视力预后差相关。
核心结论
- 在这组迄今较大的欧洲活检证实结节病系列中,随访时间较长,结节病性葡萄膜炎的全身和视觉预后均提示良好。
- 以临床孤立性葡萄膜炎起病的结节病患者在多数病例中保持严格局限于眼部。
研究设计与样本
- 回顾性研究,纳入2004年4月至2016年1月在里昂大学医院就诊的活检证实结节病性葡萄膜炎患者,要求至少随访3年。
- 共纳入83例患者,发病中位年龄52(37-62)岁,女性占77.1%。
主要发现
- 31例初诊时已有全身结节病合并眼部受累,52例初诊表现为孤立性结节病性葡萄膜炎。
- 孤立性葡萄膜炎组中7.7%(n=4)在中位随访60(44-110)个月后出现眼外病变,包括皮肤结节病(n=2)、关节炎(n=1)和多发性单神经炎(n=1)。
- 全部患者中60.2%视觉完全恢复,89.2%双眼最佳矫正视力>20/50。
- 孤立性结节病性葡萄膜炎组中2例出现单眼最佳矫正视力下降至差于20/200,无患者出现双侧严重视力损害或失明。
- 视力预后差(至少一眼最佳矫正视力≤20/50)的相关因素为慢性黄斑水肿(p=0.009)和持续性眼内炎症(p=0.0005)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To determine the long-term visual and systemic outcomes of uveitis patients with biopsy-proven sarcoidosis. METHODS: A retrospective study of biopsy-proven sarcoid uveitis, with a 3-year minimum follow-up, seen at Lyon University Hospital, between April 2004 and January 2016. RESULTS: A total of 83 patients were included, with a median age at onset of 52 (37-62) years and an unbalanced gender ratio (women 77.1%). Thirty-one patients had original systemic sarcoidosis in addition to ocular localisation, whereas 52 initially presented with isolated sarcoid uveitis. Among the latter, 7.7% (n=4) developed an extraocular disease after a median follow-up duration of 60 (44-110) months. The systemic spread in these patients included cutaneous sarcoids (n=2), arthritis (n=1) and multiple mononeuritis (n=1). Complete visual recovery was obtained for 60.2% of all patients and 89.2% had retrieved best-corrected visual acuity (BCVA) >20/50 in both eyes. A unilateral loss of BCVA of worse than 20/200 was documented in two patients in the isolated sarcoid uveitis group. No patient suffered from bilateral severe visual impairment or blindness. Factors linked to a poor visual prognosis, defined by BCVA ≤20/50 in at least one eye, were chronic macular oedema (p=0.009) and persistent ocular inflammation (p=0.0005). CONCLUSIONS: In this large European series of biopsy-proven sarcoidosis to date, with a prolonged follow-up, sarcoid uveitis was suggestive of a favourable systemic and visual outcome. Clinically isolated uveitis that revealed sarcoidosis remained a strictly ocular condition in most cases.
引用
- Rochepeau C, Jamilloux Y, Kerever S, et al. Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis. Br J Ophthalmol. 2016. PMID: 27888183. doi:10.1136/bjophthalmol-2016-309767
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。